Literature DB >> 17905371

Neurological complications of Schistosoma infection.

Francisco Javier Carod-Artal1.   

Abstract

Schistosomiasis is a parasitic disease caused by blood flukes of the genus Schistosoma. Currently more than 200 million people worldwide are affected. Neuroschistosomiasis constitutes a severe presentation of the disease. Neurological symptoms result from the inflammatory response of the host to egg deposition in the brain and spinal cord. Neurological complications of cerebral schistosomiasis include delirium, loss of consciousness, seizures, dysphasia, visual field impairment, focal motor deficits and ataxia. Cerebral and cerebellar tumour-like neuroschistosomiasis can present with increased intracranial pressure, headache, nausea and vomiting, and seizures. Myelopathy (acute transverse myelitis and subacute myeloradiculopathy) is the most common neurological complication of Schistosoma mansoni infection. Schistosomal myelopathy tends to occur early after infection and is more likely to be symptomatic than cerebral schistosomiasis. The conus medullaris and cauda equina are the most common sites of involvement. Severe schistosomal myelopathy can provoke a complete flaccid paraplegia with areflexia, sphincter dysfunction and sensory disturbances. Schistosomicidal drugs, steroids and surgery are the currently available treatments for neuroschistosomiasis. Rehabilitation and multidisciplinary team care are needed in severely disabled patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17905371     DOI: 10.1016/j.trstmh.2007.08.004

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  35 in total

1.  Pseudotumoral form of neuroschistosomiasis: report of three cases in Ganzi, China.

Authors:  Heng Wan; Hayashi Masataka; Li-Ping Zhang; De-Fu Zheng
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

2.  Evaluation of eight serological tests for diagnosis of imported schistosomiasis.

Authors:  Hans-Friedemann Kinkel; Sabine Dittrich; Britta Bäumer; Thomas Weitzel
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

3.  Research development of the pathogenesis pathways for neuroschistosomiasis.

Authors:  Peng Wang; Ming-Can Wu; Shi-Jie Chen; Guo-Cai Luo; Xiang-Ling Cheng; Zhan-Sheng Zhu; Guang-Rui Zhao
Journal:  Neurosci Bull       Date:  2010-04       Impact factor: 5.203

4.  Comparative analysis of the diagnostic performance of adult, cercarial and egg antigens assessed by ELISA, in the diagnosis of chronic human Schistosoma mansoni infection.

Authors:  Rania Mohammad Sarhan; Heba AbdelKader Aminou; Ghada Abdel Rahman Saad; Ossama Ashraf Ahmed
Journal:  Parasitol Res       Date:  2014-07-16       Impact factor: 2.289

Review 5.  Neuroschistosomiasis.

Authors:  Allen G Ross; Donald P McManus; Jeremy Farrar; Richard J Hunstman; Darren J Gray; Yue-Sheng Li
Journal:  J Neurol       Date:  2011-06-15       Impact factor: 4.849

6.  Dental archaeoparasitology: Rigorous analysis.

Authors:  J J Morrow; K J Reinhard
Journal:  Br Dent J       Date:  2016-06-24       Impact factor: 1.626

Review 7.  Urinary schistosomiasis.

Authors:  Oluwatoyin F Bamgbola
Journal:  Pediatr Nephrol       Date:  2014-01-28       Impact factor: 3.714

8.  Seroprevalence of cysticercosis in children and young adults living in a helminth endemic community in leyte, the Philippines.

Authors:  Jin-Mei Xu; Luz P Acosta; Min Hou; Daria L Manalo; Mario Jiz; Blanca Jarilla; Archie O Pablo; Remigio M Ovleda; Gretchen Langdon; Stephen T McGarvey; Jonathan D Kurtis; Jennifer F Friedman; Hai-Wei Wu
Journal:  J Trop Med       Date:  2010-03-29

9.  Medullary schistosomiasis.

Authors:  Lia Pappamikail; Paulo Fernandes; Casimiro Gonçalves
Journal:  Surg Neurol Int       Date:  2014-05-09

Review 10.  Spinal cord schistosomiasis.

Authors:  Ahmed Awad Adeel
Journal:  Sudan J Paediatr       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.